These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38151687)

  • 21. Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital.
    Rezende de Menezes R; Graciano Silva MDD; Pinho Ribeiro AL; Martins Pinto Filho M; Martinho GH; Carvalho Ferreira LE; Parreiras Martins MA
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100064. PubMed ID: 35480605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates.
    Roberts EK; Hawcutt DB; Turner MA
    Br J Clin Pharmacol; 2021 Mar; 87(3):1541-1546. PubMed ID: 32696451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
    Thomas PWA; Römkens TEH; West RL; Russel MGVM; Jansen JM; van Lint JA; Jessurun NT; Hoentjen F
    United European Gastroenterol J; 2021 Oct; 9(8):919-928. PubMed ID: 34077634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
    Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
    Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions.
    Verbič MD; Brvar M; Kos MK
    Acta Pharm; 2023 Jun; 73(2):195-210. PubMed ID: 37307369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 27. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
    Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
    Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines.
    O'Donovan B; Rodgers RM; Cox AR; Krska J
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1023-1031. PubMed ID: 31197912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea.
    Jung IY; Kim JJ; Lee SJ; Kim J; Seong H; Jeong W; Choi H; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Park JW; Kim JM
    Biomed Res Int; 2017; 2017():4304973. PubMed ID: 29457026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.
    Jarernsiripornkul N; Chaisrisawadsuk S; Chaiyakum A; Krska J
    Pharm World Sci; 2009 Oct; 31(5):559-564. PubMed ID: 19575308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review.
    Manjhi PK; Singh MP; Kumar M
    Cureus; 2024 May; 16(5):e59975. PubMed ID: 38854273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of patients' experiences and their certainty of suspected adverse drug reactions.
    Narumol J; Arunrot P; Krska J
    Int J Clin Pharm; 2015 Feb; 37(1):168-74. PubMed ID: 25576461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
    Shaikh SP; Nerurkar R
    Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.